.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Chubb
Merck
Federal Trade Commission
Moodys
Boehringer Ingelheim
Cipla
Deloitte
Accenture

Generated: December 17, 2017

DrugPatentWatch Database Preview

Levodopa - Generic Drug Details

« Back to Dashboard

What are the generic sources for levodopa and what is the scope of levodopa patent protection?

Levodopa
is the generic ingredient in three branded drugs marketed by Valeant Pharm Intl, Shire, and Roche, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for levodopa.

Medical Subject Heading (MeSH) Categories for levodopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
RocheLARODOPAlevodopaCAPSULE;ORAL016912-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ShireDOPARlevodopaTABLET;ORAL016913-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ShireDOPARlevodopaCAPSULE;ORAL016913-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
RocheLARODOPAlevodopaCAPSULE;ORAL016912-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ShireDOPARlevodopaCAPSULE;ORAL016913-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharm IntlBENDOPAlevodopaCAPSULE;ORAL016948-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ShireDOPARlevodopaCAPSULE;ORAL016913-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
RocheLARODOPAlevodopaTABLET;ORAL016912-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ShireDOPARlevodopaTABLET;ORAL016913-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
RocheLARODOPAlevodopaTABLET;ORAL016912-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chinese Patent Office
Queensland Health
Medtronic
US Army
Accenture
Healthtrust
Moodys
Cipla
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot